14 results
DEFM14A
SQZB
SQZ Biotechnologies Co
23 Jan 24
Proxy related to merger
4:31pm
, without limitation, the U.S. federal anti-kickback, fraud and abuse, false claims, consumer fraud, pricing reporting, and transparency laws and regulations … and state legislation designed to, among other things, bring more transparency to drug pricing, reduce the cost of prescription drugs under Medicare
PREM14A
SQZB
SQZ Biotechnologies Co
12 Jan 24
Preliminary proxy related to merger
8:57am
, and transparency laws and regulations as well as similar state and foreign laws in the jurisdictions outside the U.S. Violation of any such laws or any other … and proposed federal and state legislation designed to, among other things, bring more transparency to drug pricing, reduce the cost of prescription
10-K
2020 FY
SQZB
SQZ Biotechnologies Co
18 Mar 21
Annual report
6:31am
, data privacy and security, and transparency laws and regulations as well as similar state and foreign laws in the jurisdictions outside the U.S … inquiries and proposed federal and state legislation designed to, among other things, bring more transparency to drug pricing, reduce the cost
424B4
SQZB
SQZ Biotechnologies Co
12 Feb 21
Prospectus supplement with pricing info
5:10pm
resulted in several U.S. Congressional inquiries and proposed and enacted federal legislation designed to, among other things, bring more transparency … cost disclosure and transparency measures, and, in some cases, designed to encourage importation from other countries and bulk purchasing. Legally
DRS
kz4vjhqh7h
1 Feb 21
Draft registration statement
12:00am
10-Q
y12ciu5 mspnp
10 Dec 20
Quarterly report
4:46pm
424B4
3d8qct166 mh
30 Oct 20
Prospectus supplement with pricing info
4:54pm
S-1
gixj6oz 49w0mydwff
9 Oct 20
IPO registration
4:59pm
DRS/A
62tbyxit
25 Sep 20
Draft registration statement (amended)
12:00am
DRS/A
es9rxix55pv
28 Aug 20
Draft registration statement (amended)
12:00am
DRS
ofkh5mps9now
21 Jul 20
Draft registration statement
12:00am
- Prev
- 1
- Next